AATOD CMS Letter
Fentanyl Toxicology Pricing Comparison
Letter to CMS
Medicare Advantage Plans
SAMHSA Letter
AATOD CMS Letter
Fentanyl Toxicology Pricing Comparison
Letter to CMS
Medicare Advantage Plans
SAMHSA Letter

Policies impacting methadone treatment are being debated NOW.
H.R. 5629 would roll back proven OTP flexibilities—limiting access to care for patients nationwide.
We can’t go backward.
Tell Congress: Oppose H.R. 5629 and protect access to treatment:
AATOD proudly presented the world’s premier training conference event for the treatment of Opioid Use Disorder.
AATOD, Inc.
39 Broadway, Suite E26
New York, New York 10006
Contact Us
Phone
: 212-566-5555
Email
: info@aatod.org
